This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ignite Immunotherapy, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Clare Lees - Innovator in Oncolytic Virus Research
Introduction
Clare Lees is a prominent inventor based in Del Mar, CA (US). She has made significant contributions to the field of immunotherapy, particularly through her work on oncolytic viruses. Her innovative approach aims to harness the power of viruses to target and destroy cancer cells.
Latest Patents
Clare Lees holds 1 patent for her invention titled "Recombinant vaccinia virus and methods of use thereof." This patent describes a replication-competent, recombinant oncolytic vaccinia virus and the compositions that include it. The invention also outlines the use of this vaccinia virus or its compositions for inducing oncolysis in individuals with tumors.
Career Highlights
Clare is currently associated with Ignite Immunotherapy, Inc., where she continues to advance her research in the field of cancer treatment. Her work focuses on developing innovative therapies that utilize the body's immune response to combat cancer effectively.
Collaborations
Clare has collaborated with notable figures in the field, including Douglas Hanahan and David H Kirn. These partnerships have further enriched her research and contributed to the advancement of oncolytic virus therapies.
Conclusion
Clare Lees is a trailblazer in the realm of oncolytic virus research, with her innovative patent paving the way for new cancer treatment strategies. Her dedication to advancing immunotherapy continues to inspire progress in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile